Our Culture
What you believe and what you value as an organization matters. Discover the DNA of our firm.
Sr. Research Analyst
2024
Wafra (2022 - 2024)
New York, NY | Director
Franklin Templeton (2017 - 2022)
San Francisco, CA | Analyst/Portfolio Manager
BNP Paribas Corporate & Investment Bank (2016 - 2017)
New York, NY | Analyst
Oak Hill Advisors (2014 - 2016)
New York, NY | Associate
Falcon Point Capital (2009 - 2013)
San Francisco, CA | Associate
University of California, Berkeley (2008)
BA | Slavic Languages and Area Studies
Kelly is a senior research analyst covering life sciences. She joined Sands Capital in 2024, bringing significant experience investing in therapeutics, in tools and devices, and in ex-U.S. opportunities.
Before joining the firm, Kelly was a director and the global healthcare sector head for Wafra, an alternative asset management firm owned by the Public Institution for Social Security of Kuwait. She also worked as a research analyst on innovative technology businesses at Franklin Templeton, where she was a co-portfolio manager on strategies focused on genomics and medical devices. In addition, she was a commodity trading analyst at BNP Paribas, a fixed income analyst at Oak Hill Advisors, and a long/short research associate at Falcon Point Capital.
Kelly received a BA from the University of California, Berkeley. She is a CFA® charterholder.
Notice for non-US Investors
